2024
Benboubker V, Ramzy GM, Jacobs S, Nowak-Sliwinska P, Challenges in validation of combination treatment strategies for CRC using patient-derived organoids, under review
Gubala J, Mieville V, Benamran D, Valerio M, Tille JC, Nowak-Sliwinska P, Generation and maintenance of kidney and kidney cancer organoids from patient-derived material for drug development and precision oncology, under review
Zebret S, Hadiji M, Romano-deGea J, Bornet A, Ortiz D, Fadaei TD, Stathopoulos C, Nowak-Sliwinska P, Munier F, Dyson PJ, New melphalan derivatives for the treatment of retinoblastoma in combination with thermotherapy,RSC Med. Chem., 2024, 15, 2300. doi: 10.1039/d4md00211c
Dugershaw-Kurzer B, Bossart J, Buljan M, Hannig Y, Zehnder S, Gupta GS, Kissling VS, Nowak-Sliwinska P, van Beijnum JR, Griffioen AW, Masjosthusmann S, Zühr E, Fritsche E, Hornung R, Rduch T, Buerki-Thurnherr T, Uncovering the role of nanoparticles in disrupting placental secretome and its consequences on angiogenesis and neurodevelopment, Advanced Science.(2024) May 20:e2401060. doi: 10.1002/advs.202401060 (IF 15.4)
2023
Poinot H, Dupuychaffray E, Arnoux G, Alvarez M, Tachet J, Ezzar O, Moore J, Bejuy O, Olesti E, Gonzalez Ruiz V, Rudaz S, Tille J-C, Vögel C, NowakSliwinska P, Bourquin C, Pommier A, Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer, Oncoimmunology. 2023 Nov 30;13(1):2286820. doi: 10.1080/2162402X.2023.2286820 (IF 7.72)
Nowak-Sliwinska P, Griffioen AW, Rising impact of cell death research, Apoptosis, (2023), 28(11-12):1503-1504. doi: 10.1007/s10495-023-01895-5 (IF 7.21)
Mieville V, Griffioen AW, Benamran D, Nowak-Sliwinska P, Advanced in vitro models for renal cell carcinoma therapy design, Biochem Biophys Acta Rev Cancer, (2023)1878(5):188942, doi: 10.1016/j.bbcan.2023.188942 (IF 11.41)
Ramzy GM, Norkin M, Koessler T, Voirol L, Tihy M, Hany D, McKee T, Ris F, Buchs N, Docquier M, Toso C, Rubbia-Brandt L, Bakalli G, Guerrier S, Huelsken J, Nowak-Sliwinska P, Platform conbining mathematical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma, Journal of Experimental & Clinical Cancer Research, (2023) 42:79, doi.org/10.1186/s13046-023-02650-z (IF 12.66)
Schelker C, Nowak-Sliwinska P, Borchard G, Liposomal delivery systems for drug combinations in cancer treatment, Journal of Controlled Release, (2023) 358:59-77, doi: 10.1016/j.jconrel.2023.04.006 (IF 11.47)
Hany D, Zoetemelk M, Bhattacharya K, Nowak-Sliwinska P, Picard D, Network-informed discovery of multidrug combinations forERα+/HER2-/PI3Kα-mutant breast cancer, Cell Mol Life Sci. 2023 Mar 3;80(3):80. doi: 10.1007/s00018-023-04730-x (IF 9.78)
Nowak-SliwinskA P, van Beijnum JR, Griffioen JR, Huinen ZR, Grima Sopesens N, Schulz R, Jenkins SV, RPM Dings, Groenendijk FH, Huijbers EJM, Thijssen V, Jonasch E, Vyth-Dreese FA, Jordanova ES, Bex A, Bernards R, de Gruijl TD, Griffioen AW, Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy, Angiogenesis, (2023) 26(2):279-293, doi: 10.1007/s10456-022-09863-4 (IF 10.66)
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010